The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Vol. 60. Issue 3.
Pages 286-287 (1 March 2004)
Vol. 60. Issue 3.
Pages 286-287 (1 March 2004)
Full text access
Síndrome de Rasmussen
Visits
10831
A. Verdú Pérez
, P. Castro de Castro, G. Arriola Pereda
Corresponding author
averdu@sescam.jccm.es
Correspondencia: Sección de Neurología Pediátrica. Dr. Castelo, 49. 28009 Madrid. España.
Correspondencia: Sección de Neurología Pediátrica. Dr. Castelo, 49. 28009 Madrid. España.
Sección de Neurología Pediátrica. Hospital Universitario Gregorio Marañón. Dr. Castelo, 49. 28007 Madrid. España
This item has received
Article information
Full text is only available in PDF
Bibliografía
[1.]
A. Carrillo Herranz, I. Sánchez Pérez, J.M. Aparicio Meix, C. Lozano Jiménez, G. Roy Ariño, L.M. Villar Gamerans, et al.
Síndrome de Rasmussen: una enfermedad autoinmune.
An Pediatr (Barc), 59 (2003), pp. 187-189
[2.]
Commission on Classification.
Proposal for revised classification of epilepsies and epileptic syndromes.
Epilepsia, 30 (1989), pp. 389-399
[3.]
N.K. So, F. Andermann.
Rasmussen’s Syndrome.
Epilepsy. A Comprehensive Textbook, pp. 2379-2388
[4.]
R.C. Dale.
El estreptococo piógenes y el cerebro: viviendo con el enemigo.
Rev Neurol, 37 (2003), pp. 92-97
[5.]
S.J. Perlmutter, S.F. Leitman, M.A. Garvey, S. Hamburger, E. Feldman, H.L. Leonard, et al.
Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.
Lancet, 354 (1999), pp. 1153-1158
Copyright © 2004. Asociación Española de Pediatría


